Get the latest tech news
23andMe Is Under Fire. Its Founder Remains ‘Optimistic’
23andMe’s CEO Anne Wojcicki has saved the genetics company from the brink of failure before. She sat down with WIRED to talk about where it goes from here.
Founded in 2006, it’s best known as a genetic testing company that provides insights into people’s ancestry and health risks from tubes of spit they send through the mail. Wojcicki has saved 23andMe from the brink of failure before—notably after the US Food and Drug Administration ordered the company in 2013 to stop marketing its health risk assessments to customers until the business could validate them, which took several years. But a decade later, the challenges are bigger and the solutions less clear: 23andMe needs to rebuild trust after its data breach, convince customers that it is a subscriptions business, and find new investors and industry partners to support its forays into drug development.
Or read this on Wired
